In this study, our aim is to determine an active but tolerable sublingual dose (range 100 to 4000 µg) of Salvinorin A (SA) in experienced subjects.
Ascending-dose, placebo-controlled, single-site study in 8 Salvia-experienced participants to determine tolerable sublingual doses of Salvinorin A.
Participants receive single-dose sublingual administrations separated by at least one day; doses include 0, 100, 250, 500, 1000, 2000 and 4000 µg; first two doses reportedly double-blinded with later doses single-blind per protocol text.
Ascending-dose sublingual Salvinorin A (0–4000 µg) in experienced subjects.
Salvinorin A sublingual ascending doses: 0, 100, 250, 500, 1000, 2000, 4000 µg; doses separated by ≥1 day.
Matched sublingual placebo.
Matching placebo administered in dose-escalation schedule.